{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:24Z","timestamp":1792787304490,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["NRF-2021R1A6A1A03038899"],"award-info":[{"award-number":["NRF-2021R1A6A1A03038899"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY-202400000001258"],"award-info":[{"award-number":["HY-202400000001258"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,9,14]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/rmdopen-2026-007179","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:40:27Z","timestamp":1792762827000},"page":"e007179","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world association of biologic and targeted synthetic DMARD use with mortality in rheumatoid arthritis-associated interstitial lung disease: a nationwide cohort study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-8996","authenticated-orcid":false,"given":"Young Bin","family":"Joo","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea"},{"name":"Hanyang University Institute for Rheumatology Research, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soorack","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, Hanyang University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwon","family":"Go","sequence":"additional","affiliation":[{"name":"Biostatistical Consulting and Research Lab, Medical Research Collaborating Center, Hanyang University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-9350","authenticated-orcid":false,"given":"So-Young","family":"Bang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea"},{"name":"Hanyang University Institute for Rheumatology Research, Seoul, Korea"},{"name":"Hanyang Institute of Bioscience and Biotechnology, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1414-4817","authenticated-orcid":false,"given":"Sang-Cheol","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea"},{"name":"Hanyang University Institute for Rheumatology Research, Seoul, Korea"},{"name":"Hanyang Institute of Bioscience and Biotechnology, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Soon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea"},{"name":"Hanyang University Institute for Rheumatology Research, Seoul, Korea"},{"name":"Hanyang Institute of Bioscience and Biotechnology, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2026102306402043000_12.4.e007179.1","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/art.40574","article-title":"The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease","volume":"70","author":"Spagnolo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2026102306402043000_12.4.e007179.2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/art.42640","article-title":"Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease","volume":"75","author":"Koduri","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026102306402043000_12.4.e007179.3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.chest.2025.11.033","article-title":"Subclinical Interstitial Lung Disease in Rheumatoid Arthritis: Implications for Early Detection and Management","volume":"169","author":"Ormsby","year":"2026","journal-title":"Chest"},{"key":"2026102306402043000_12.4.e007179.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211138"},{"key":"2026102306402043000_12.4.e007179.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171315"},{"key":"2026102306402043000_12.4.e007179.6","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003680","article-title":"PM10 increases mortality risk in rheumatoid arthritis-associated interstitial lung disease","volume":"10","author":"Kim","year":"2024","journal-title":"RMD Open"},{"key":"2026102306402043000_12.4.e007179.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3781-7"},{"key":"2026102306402043000_12.4.e007179.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa836"},{"key":"2026102306402043000_12.4.e007179.9","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/acr.24856","article-title":"Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort","volume":"74","author":"Samhouri","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026102306402043000_12.4.e007179.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead027"},{"key":"2026102306402043000_12.4.e007179.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"2026102306402043000_12.4.e007179.12","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3282f4b392"},{"key":"2026102306402043000_12.4.e007179.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq242"},{"key":"2026102306402043000_12.4.e007179.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005615","article-title":"Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis","volume":"4","author":"Nakashita","year":"2014","journal-title":"BMJ Open"},{"key":"2026102306402043000_12.4.e007179.15","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S204730"},{"key":"2026102306402043000_12.4.e007179.16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3640","article-title":"Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs","volume":"6","author":"Baker","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026102306402043000_12.4.e007179.17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/acr.25348","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026102306402043000_12.4.e007179.18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ard.2025.08.021","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"85","author":"Antoniou","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"2026102306402043000_12.4.e007179.19","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2022.11.2.103"},{"key":"2026102306402043000_12.4.e007179.20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00296-017-3925-9","article-title":"Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization","volume":"38","author":"Won","year":"2018","journal-title":"Rheumatol Int"},{"key":"2026102306402043000_12.4.e007179.21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2019.11.007","article-title":"An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea","volume":"50","author":"Kim","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2026102306402043000_12.4.e007179.22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/acr.25053","article-title":"A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis","volume":"75","author":"Johnson","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026102306402043000_12.4.e007179.23","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003491","article-title":"Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database","volume":"9","author":"Juge","year":"2023","journal-title":"RMD Open"},{"key":"2026102306402043000_12.4.e007179.24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.120626"},{"key":"2026102306402043000_12.4.e007179.25","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003789","article-title":"Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register","volume":"10","author":"Rudi","year":"2024","journal-title":"RMD Open"},{"key":"2026102306402043000_12.4.e007179.26","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/S2665-9913(24)00265-0","article-title":"Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study","volume":"7","author":"England","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"2026102306402043000_12.4.e007179.27","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003487","article-title":"Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"9","author":"Yuan","year":"2023","journal-title":"RMD Open"},{"key":"2026102306402043000_12.4.e007179.28","doi-asserted-by":"crossref","first-page":"103636","DOI":"10.1016\/j.autrev.2024.103636","article-title":"Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis","volume":"23","author":"Narv\u00e1ez","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2026102306402043000_12.4.e007179.29","doi-asserted-by":"crossref","first-page":"152636","DOI":"10.1016\/j.semarthrit.2025.152636","article-title":"Mortality and medical utilization in rheumatoid arthritis associated interstitial lung disease: A real-world, large-scale retrospective study comparing Janus kinase inhibitors and tumor necrosis factor inhibitors","volume":"71","author":"Shih","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026102306402043000_12.4.e007179.30","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15164","article-title":"JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation","volume":"27","author":"Wei","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"2026102306402043000_12.4.e007179.31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s42358-023-00325-z","article-title":"Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2\/Stat3 signaling pathway","volume":"63","author":"Liu","year":"2023","journal-title":"Adv Rheumatol"},{"key":"2026102306402043000_12.4.e007179.32","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101436R","article-title":"Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis","volume":"36","author":"Wang","year":"2022","journal-title":"FASEB J"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2026-007179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:40:30Z","timestamp":1792762830000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2026-007179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,10,23]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/rmdopen-2026-007179"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2026-007179","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}